Physica Medica: European Journal of Medical Physics
Volume 21 , Pages 24-27 , 2006

Functional imaging of multidrug resistance in breast cancer

  • Silvana Del Vecchio

      Affiliations

    • Institute of Biostructures and Biomages of the National Research Council (CNR), Naples (Italy)
    • Institute of Biostructures and Biomages of the National Research Council (CNR), Naples (Italy)
    • Corresponding Author InformationAddress for correspondence: S. Del Vecchio, Istituto di Biostructure e Bioimmagini, cnr, Via S. Pansini, 5 Edificio 10, I 80131 Naples (Italy). Fax: +39 39081-5457081.
    • ,
  • Antonella Zannetti

      Affiliations

    • Institute of Biostructures and Biomages of the National Research Council (CNR), Naples (Italy)
    • ,
  • Barbara Salvatore

      Affiliations

    • Department of Biomorphological and Functional Sciences, University «Federico II, Naples (Italy)
    • ,
  • Gaetano Paone

      Affiliations

    • Department of Biomorphological and Functional Sciences, University «Federico II, Naples (Italy)
    • ,
  • Rosa Fonti

      Affiliations

    • Institute of Biostructures and Biomages of the National Research Council (CNR), Naples (Italy)
    • ,
  • Marco Salvatore

      Affiliations

    • Department of Biomorphological and Functional Sciences, University «Federico II, Naples (Italy)

References 

  1. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002;2:48–58
  2. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation. 1990;82:1826–1838
  3. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A, Jones AG. Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res. 1990;50:2198–2202
  4. Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones AG, Holman BL, et al. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med. 1992;33:1516–1522
  5. Crankshaw CL, Marmion M, Luker GD, Rao V, Dahlheimer J, Burleigh BD, et al. Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein. J Nucl Med. 1998;39:77–86
  6. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res. 1993;53:977–984
  7. Piwnica-Worms D, Rao VV, Kronauge JF, Croop JM. Characterization of multidrug resistance P-glyco-protein transport function with an organotechnetium cation. Biochemistry. 1995;34:12210–12220
  8. Ballinger JR, Bannerman J, Boxen I, Firby P, Hartman NG, Moore MJ. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multi-drug-resistant breast tumor cells. J Nucl Med. 1996;37:1578–1582
  9. Ballinger JR, Muzzammil T, Moore MJ. Technetium-99m-furifosmin as an agent for functional imaging of multidrug resistance in tumors. J Nucl Med. 1997;38:1915–1919
  10. Hendrikse NH, Franssen EJ, van der Graaf WT, Vaalburg W, de Vries EG. Visualization of multidrug resistance in vivo. Eur J Nucl Med. 1999;26:283–293
  11. Trock BJ, Leonessa F, Clarke R. Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance. J Natl Cancer Inst. 1997;89:917–931
  12. Del Vecchio S, Ciarmiello A, Potena MI, Carriero MV, Mainolfi C, Botti G, et al. In vivo detection of multi-drug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients. Eur J Nucl Med. 1997;24:150–159
  13. Ciarmiello A, Del Vecchio S, Silvestro P, Potena MI, Carriero MV, Thomas R, et al. Tumor clearance of technetium 99m-sestaMIBI as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol. 1998;16:1677–1683
  14. Sciuzo R, Pasqualoni R, Bergomi S, Petrilli G, Vici P, Belli F, et al. Prognostic value of (99m) Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy. J Nucl Med. 2002;43:745–751
  15. Fujii H, Nakamura K, Kubo A, Enomoto K, Ikeda T, Kuppta T, et al. Preoperative evaluation of the chemosensitivity of breast cancer by means of double phase 99mTc-MIBI scintimammography. Ann Nucl Med. 1998;12:307–312
  16. Takamura Y, Miyoshi Y, Taguchi T, Noguchi S. Prediction of chemotherapeutic response by Technetium 99m MIBI scintigraphy in breast carcinoma patients. Cancer. 2001;92:232–239
  17. Mubashar M, Harrington KJ, Chaudhary KS, Lalaniel N, Stamp GW, Sinnett D, et al. 99mTc-sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer. J Nucl Med. 2002;43:519–525
  18. Cavre A, Cachin F, Maublant J, Mestas D, Feillel V, Ferriere JP, et al. Single static view 99mTc-sestamibi scintimammography predicts response to neoadjuvant chemotherapy and is related to MDR expression. Int J Oncol. 2002;20:1049–1055
  19. Fuster D, Munoz M, Pavia J, Palacin A, Bellet N, Mateos JJ, et al. Quantified 99mTc-MIBI scintigraphy for predicting chemotherapy response in breast cancer patients: factors that influence the level of 99m Tc-MIBI uptake. Nucl Med Commun. 2002;23:31–38
  20. Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2002;2:277–288
  21. Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis. Trends Cell Biol. 2000;10:369–377
  22. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med. 2000;6:513–519
  23. Cory S, Adams JM. The bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2002;2:647–656
  24. Del Vecchio S, Zannetti A, Aloj L, Caraco C, Ciarmiello A, Salvatore M. Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma. Eur J Nucl Med Mol Imaging. 2003;30:879–887
  25. Aloj L, Zannetti A, Caraco C, Del Vecchio S, Salvatore M. Bcl-2 overexpression prevents (99m)Tc-MIBI uptake in breast cancer cell lines. Eur J Nucl Med Mol Imaging. 2003;

PII: S1120-1797(06)80019-0

doi: 10.1016/S1120-1797(06)80019-0

Physica Medica: European Journal of Medical Physics
Volume 21 , Pages 24-27 , 2006

Article Tools